PUBLISHER: TechNavio | PRODUCT CODE: 2109665
PUBLISHER: TechNavio | PRODUCT CODE: 2109665
Global Ambulatory Cardiac Monitoring Devices Market 2026-2030
The global ambulatory cardiac monitoring devices market is forecasted to grow by USD 2686.2 mn during 2025-2030, accelerating at a CAGR of 6.7% during the forecast period. The report on the global ambulatory cardiac monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding remote patient monitoring partnerships accelerates outpatient cardiac care adoption, ai integration enhances handheld twelve lead electrocardiogram diagnostic precision, direct electronic health record workflows streamline ambulatory cardiac data delivery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.5% |
| CAGR | 6.7% |
| Incremental Value | $2686.2 mn |
Technavio's global ambulatory cardiac monitoring devices market is segmented as below:
By Device
- Ambulatory ECG devices
- Ambulatory cardiac event monitors
- Ambulatory cardiac telemetry devices
- Implantable loop recorders
By End-User
- Ambulatory care centers
- Hospitals
- Clinics and cardiac centers
By Modality
- Wireless devices
- Wired devices
Geography
- North America
- US
- Canada
- Mexico
- Asia
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the fourteen day continuous patch ecg monitoring replaces short duration devices as one of the prime reasons driving the global ambulatory cardiac monitoring devices market growth during the next few years. Also, device neutral software aggregation unifies fragmented outpatient remote telemetry networks and three dimensional vector cardiographic signal processing enables home twelve lead synthesis will lead to sizable demand in the market.
The report on the global ambulatory cardiac monitoring devices market covers the following areas:
- Global ambulatory cardiac monitoring devices market sizing
- Global ambulatory cardiac monitoring devices market forecast
- Global ambulatory cardiac monitoring devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ambulatory cardiac monitoring devices market vendors that include Abbott Laboratories, ACS Diagnostics Inc., Baxter International Inc., Bionet Co. Ltd., Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES, Cardiac Insight Inc., Cardioline SpA, Cortrium Aps, GE HealthCare Technologies, iRhythm Technologies Inc., Koninklijke Philips NV, Labtech Ltd., Lepu Medical Co. Ltd., Medicalgorithmics S.A., Nihon Kohden Corp., Norav Medical, SCHILLER AG, VivaLNK Inc., ZOLL Medical Corp.. Also, the global ambulatory cardiac monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Device
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Modality
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Ambulatory Cardiac Monitoring Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Ambulatory Cardiac Monitoring Devices Market 2020 - 2024 ($ million)
- 5.2 Device segment analysis 2020 - 2024
- Historic Market Size - Device Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Modality segment analysis 2020 - 2024
- Historic Market Size - Modality Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global ambulatory cardiac monitoring devices market
- 6.2 Impact of geopolitical conflicts on global ambulatory cardiac monitoring devices market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Device
- 8.1 Market segments
- 8.2 Comparison by Device
- 8.3 Ambulatory ECG devices - Market size and forecast 2025-2030
- 8.4 Ambulatory cardiac event monitors - Market size and forecast 2025-2030
- 8.5 Ambulatory cardiac telemetry devices - Market size and forecast 2025-2030
- 8.6 Implantable loop recorders - Market size and forecast 2025-2030
- 8.7 Market opportunity by Device
- Market opportunity by Device ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Ambulatory care centers - Market size and forecast 2025-2030
- 9.4 Hospitals - Market size and forecast 2025-2030
- 9.5 Clinics and cardiac centers - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Modality
- 10.1 Market segments
- 10.2 Comparison by Modality
- 10.3 Wireless devices - Market size and forecast 2025-2030
- 10.4 Wired devices - Market size and forecast 2025-2030
- 10.5 Market opportunity by Modality
- Market opportunity by Modality ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Asia - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 Japan - Market size and forecast 2025-2030
- 12.4.3 India - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Singapore - Market size and forecast 2025-2030
- 12.4.6 Taiwan - Market size and forecast 2025-2030
- 12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 UK - Market size and forecast 2025-2030
- 12.5.3 France - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.6.6 UAE - Market size and forecast 2025-2030
- 12.6.7 Israel - Market size and forecast 2025-2030
- 12.6.8 Chile - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Expanding remote patient monitoring partnerships accelerates outpatient cardiac care adoption
- AI integration enhances handheld twelve lead electrocardiogram diagnostic precision
- Direct electronic health record workflows streamline ambulatory cardiac data delivery
- 13.2 Market challenges
- Strict reimbursement governance restricts financial feasibility across outpatient cardiac diagnostics
- Company fragmentation prevents seamless electronic health record system data interoperability
- Cybersecurity vulnerabilities jeopardize data privacy in connected remote cardiac sensors
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Fourteen day continuous patch ECG monitoring replaces short duration devices
- Device neutral software aggregation unifies fragmented outpatient remote telemetry networks
- Three dimensional vector cardiographic signal processing enables home twelve lead synthesis
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.6 Bionet Co. Ltd.
- Bionet Co. Ltd. - Overview
- Bionet Co. Ltd. - Product / Service
- Bionet Co. Ltd. - Key offerings
- SWOT
- 15.7 Boston Scientific Corp.
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
- 15.8 BPL MEDICAL TECHNOLOGIES
- BPL MEDICAL TECHNOLOGIES - Overview
- BPL MEDICAL TECHNOLOGIES - Product / Service
- BPL MEDICAL TECHNOLOGIES - Key offerings
- SWOT
- 15.9 Cardioline SpA
- Cardioline SpA - Overview
- Cardioline SpA - Product / Service
- Cardioline SpA - Key offerings
- SWOT
- 15.10 GE HealthCare Technologies
- GE HealthCare Technologies - Overview
- GE HealthCare Technologies - Business segments
- GE HealthCare Technologies - Key news
- GE HealthCare Technologies - Key offerings
- GE HealthCare Technologies - Segment focus
- SWOT
- 15.11 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
- 15.12 Labtech Ltd.
- Labtech Ltd. - Overview
- Labtech Ltd. - Product / Service
- Labtech Ltd. - Key offerings
- SWOT
- 15.13 Lepu Medical Co. Ltd.
- Lepu Medical Co. Ltd. - Overview
- Lepu Medical Co. Ltd. - Product / Service
- Lepu Medical Co. Ltd. - Key offerings
- SWOT
- 15.14 Medicalgorithmics S.A.
- Medicalgorithmics S.A. - Overview
- Medicalgorithmics S.A. - Product / Service
- Medicalgorithmics S.A. - Key offerings
- SWOT
- 15.15 Nihon Kohden Corp.
- Nihon Kohden Corp. - Overview
- Nihon Kohden Corp. - Business segments
- Nihon Kohden Corp. - Key offerings
- Nihon Kohden Corp. - Segment focus
- SWOT
- 15.16 SCHILLER AG
- SCHILLER AG - Overview
- SCHILLER AG - Product / Service
- SCHILLER AG - Key offerings
- SWOT
- 15.17 VivaLNK Inc.
- VivaLNK Inc. - Overview
- VivaLNK Inc. - Product / Service
- VivaLNK Inc. - Key offerings
- SWOT
- 15.18 ZOLL Medical Corp.
- ZOLL Medical Corp. - Overview
- ZOLL Medical Corp. - Product / Service
- ZOLL Medical Corp. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
